Tag

• UGI USER
• access to medicines affordable medicines bedaquiline BPaL regimen drug-resistant TB generic drugs India TB drug patent Indian Patent Office linezolid MDR-TB PRETOMANID public health TB Alliance
• 11
• 0

India Rejects TB Drug Patent for Affordable Care

INDIA REJECTS TB DRUG PATENT TO IMPROVE AFFORDABILITY WHY IN THE NEWS ? The Indian Patent Office has rejected a patent application for the BPaL tuberculosis drug combination, potentially encouraging generic competition, reducing treatment costs and improving access to shorter treatment for patients suffering from drug-resistant tuberculosis. PATENT REJECTION AND KEY FEATURES OF BPaL TREATMENT: …